Lucid Diagnostics Inc. (LUCD) Total liabilities 2021–2025
Lucid Diagnostics Inc. (LUCD) total liabilities at each fiscal year-end, per SEC filings.
$29.5MFY2025 · since FY2021: $4.3M → $29.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29.5M | +16.5% |
| FY2024 | $25.3M | -14.4% |
| FY2023 | $29.6M | +212.6% |
| FY2022 | $9.5M | +122.1% |
| FY2021 | $4.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More LUCD financial trends
LUCD RevenueLUCD Net incomeLUCD Net marginLUCD Gross profitLUCD Gross marginLUCD Operating incomeLUCD Operating marginLUCD Operating cash flowLUCD Free cash flowLUCD Capital expendituresLUCD Return on equityLUCD Stock buybacksLUCD Dividends paidLUCD Total assetsLUCD Shareholders’ equityLUCD overview →